Breast Imaging Market size is projected to experience significant growth from 2022 to 2028 owing to increasing cases of breast-related diseases, including lesions, infections and fibrocytes. Besides, soaring cases of breast cancer in the U.S., the U.K. and Australia will contribute to the growth of breast imaging. According to the WHO, there were approximately 2.3 million women diagnosed with breast cancer, while around 685,000 succumbed to it globally.
Breast imaging has become instrumental for diagnostic or imaging purposes, using mammography thermography and ultrasound, among others. Industry participants are using a host of technologies and tools to detect, screen and diagnose breast cancer. Notably, breast ultrasound has become sought-after to show the blood flow and tissue composition. Radiologists are counting on ultrasound as a painless and standard additional test to assess areas of concern.
In terms of technology, global breast imaging market share from mammography will expand through 2028. Mammography has become popular for the early detection and diagnosis of breast diseases. Recent advances, such as digital-aided detection (CAD) and digital mammography are likely to boost the industry outlook. Prominently, organizations have exhibited traction for screening mammography to enhance the ability to detect small tumors and detection of small abnormal tissue growths.
Based on end-use, hospitals are likely to account for a notable share of breast imaging market due to the increased healthcare budget. Breast imaging services, such as tomosynthesis, ultrasound and thermography have become pronounced. Additionally, AI applications have become trendier in the healthcare sector to assess large data sets and provide predictive analysis to help in diagnosis.
North America breast imaging market share will expand with rising investments in healthcare infrastructure and the soaring burden of breast cancer. Breastcancer.org estimated around 281,550 new cases of invasive breast cancer in women in the U.S., while approximately 2,650 new cases of invasive breast cancer were estimated to be diagnosed in men in 2021. The presence of leading companies, rising cases of breast cancer and increasing geriatric population will drive the market growth in the region.
Global market is competitive owing to the presence of leading companies, including Koninklijke Philips N.V., Canon Medical Systems Corporation, Delphinus Medical Technologies, Inc., Aurora Healthcare, Fujifilm Corporation, CMR Naviscan, Siemens Healthcare, Metaltronica, Supersonic Imagine, SonoCine, General Electric Company, Medi-future, Hologic, Inc. and Planmed OY. The competitive landscape indicates key players could emphasize mergers & acquisitions, product launches, R&D activities and innovations.
In December 2020, Hologic, Inc. announced U.S. FDA clearance and commercial availability of its AI detection technology to help radiologists detect potential cancers in breast tomosynthesis images. The company believes it would help enhance cancer detection, foster patient experience, and optimize workflow.
The novel strain of coronavirus has posed challenges to the healthcare industry following the delay or postponement of screening breast imaging exams. With the COVID-19 vaccine in full swing, governments and other stakeholders are expected to raise awareness and inject funds. In November 2020, the Canadian Partnership Against Cancer announced an investment of around USD 24.5 million to address the needs of cancer patients during the outbreak. Besides, they have implemented the Canadian Strategy for Cancer Control 2019-2029 to boost innovations.
As the healthcare sector seeks new ways to bolster access to quality care, well-established organizations are likely to adopt innovations and improvements to optimize breast cancer services. Technologically advanced breast imaging procedures are poised to gain traction to provide accurate clinical information and aid physicians in making treatment and diagnoses plans.
Market, by Technology
Market, by End-use
The above information is provided for the following regions and countries: